Subjective and objective risk of breast cancer in Ashkenazi Jewish individuals at risk for BRCA1/2 mutations

Genetic Testing

Volumn 8, Issue 2, 2004, Pages 139-147

  Kelly, Kimberly ^a   Leventhal, Howard ^b   Marvin, Monica ^c   Toppmeyer, Deborah ^d   Much, Judith ^d   Dermody, James ^e   Baran, Jill ^d   Schwalb, Marvin ^e  

^a OHIO STATE UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c SPECTRUM HEALTH   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; BRCA2 GENE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC COUNSELING; HUMAN; JEW; MAJOR CLINICAL STUDY; ONCOGENE; ONSET AGE; PROGNOSIS; SURVIVAL TIME;

AGE OF ONSET; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; JEWS; MIDDLE AGED; MUTATION; QUESTIONNAIRES; RISK;

EID: 4143135252     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/1090657041797392     Document Type: Article

References (34)

1. AJZEN, I., and FISHBEIN, M. (1980). Understanding Attitudes and Predicting Social Behavior. Prentice Hall, Englewood Cliffs, NJ.
2. BATY, B.J., VENNE, V.L., MCDONALD, J., et al. (1997). BRCA1 Testing: Genetic counseling protocol development and counseling issues. J. Genet. Couns. 6, 223-244.
3. BECKER, M.H. (1974). The health belief model and sick role behavior. Health Educ Monogr. 2, 409-419.
4. BERRY, D.A., PARMIGIANI, G., SANCHEZ, J., et al. (1997). Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J. Natl. Cancer Inst. 89, 227-237.
5. CLAUS, E.B., RISCH, N.J., and THOMPSON, W.D. (1990). Age at onset as an indicator of familial risk of breast cancer. Am. J. Epidemiol. 131, 961-972.
6. CLAUS, E.B., RISCH, N.J., and THOMPSON, W.D. (1994). Autosomal dominant inheritance of early-onset breast cancer. Cancer 73, 643-651.
7. CODORI, A., HANSON, R., and BRANDT, J. (1994). Self-selection in predictive testing for Huntington's Disease. Am. J. Med. Genet. 54, 167-173.
8. COOK, L.S., WHITE, E., SCHWARTZ, S.M., et al. (1996). A population-based study of contralateral breast cancer following a first primary breast cancer. Cancer Causes Control. 7, 382-390.
9. EVANS, D.G.R., BURNELL, L.D., HOPWOOD, P., et al. (1993). Perception of risk in women with a family history of breast cancer. Br. J. Cancer. 67, 612-614.
10. EVANS, D.G.R., BLAIR, V., GREENHALGH, R., et al. (1994). The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br. J. Cancer. 70, 934-938.
11. FORD, D., EASTON, D.F., BISHOP, D.T., et al. (1994). Risks of cancer in BRCA1-mutation carriers. Lancet 343, 692-695.
12. FRANK, T.S., MANLEY, S.A., OLOPADE, O.I., et al. (1998). Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J. Clin. Oncol. 16, 2417-2425.
13. GAIL, M.H., and BENICHOU, J. (1992). Assessing the risk of breast cancer in individuals. In Cancer Prevention. V.T. DeVita, Jr., S. Hellman, S.A. Rosenberg (eds.), Lippincott, Philadelphia, pp. 1-15.
14. HALL, J.M., LEE, M.K., NEWMAN, B., et al. (1990). Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684-1689.
15. KELLY, K., LEVENTHAL, H., TOPPMEYER, D., et al. (2003). Subjective and objective risks of carrying a BRCA1/2 mutation in individuals of Ashkenazi Jewish descent. J. Genet. Couns. 12, 351-371.
16. LACHENMEYER, S. (1995). "Decision to participate in genetic screening." Unpublished undergraduate honor's thesis, Rutgers University, New Brunswick, NJ.
17. LERMAN, C., LUSTBADER, E., RIMER, B., et al. (1995). Effects of individualized breast cancer risk counseling: a randomized trial. J. Natl. Cancer Inst. 87, 286-292.
18. LERMAN, C., BIESECKER, B., BENKENDORF, J., et al. (1997). Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J. Natl. Cancer Inst. 89, 148-157.
19. LERMAN, C., HUGHES, C., and CROYLE, R. (2000). Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev. Med. 31, 75-80.
20. LEVENTHAL, H., DIEFENBACH, M.A., and LEVENTHAL, E.A. (1992). Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cognit. Ther. Res. 16, 143-163.
21. LEVENTHAL, H., KELLY, K., and LEVENTHAL, E. (1999). Population risk, actual risk, perceived risk and cancer control: A discussion. J. Natl. Cancer Inst. Monogr. 25, 81-85.
22. MARCUS, J., WATSON, P., PAGE, D.L., et al. (1996). Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77, 697-709.
23. OLAH, E., NEMETH, G., and PAPP, J. (1997). BRCA 1 and other chromosome 17 genes in pathogenesis of multiple primary cancers (MPC). Proc. Ann. Meeting Am. Assn. Cancer Res. 38, A1124.
24. PARMIGIANI, G., BERRY, D.A., and AGUILAR, O. (1998). Modeling risk of breast cancer and decisions bout genetic testing. Am. J. Hum. Genet. 62, 145-148.
25. ROA, B., BOYD, A., VOLCIK, K., et al. (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genet. 14, 185-187.
26. ROGERS, R.W. (1975). A protection motivation theory of fear appeals and attitude change. J. Psychol. 91, 93-114.
27. SHILOH, S., and SAGI, M. (1989). Effect of framing on the perception of genetic recurrence risks. Am. J. Med. Genet. 33, 1435-1437.
28. SKINNER, C.S., SCHILDKRAUT, J.M., BERRY, D., et al. (2002). Pre-counseling education materials for BRCA testing: Does tailoring make a difference? Genet. Test. 6(2), 93-105.
29. STRUEWING, J.P., HARTGE, P., WACHOLDER, S., BAKER, S.M., BERLIN, M., MCADAMS, M., TIMMERMAN, M.M., et al. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med. 336(20), 1401-1408.
30. TEL'KINA, G.N., and SORKIN, V.M. (1998). The incidence of bilateral multiple primary cancer among the female inhabitants of Crimea. Likarska Sprava 6, 143-145.
31. TONIN, P., WEBER, B., OFFIT, K., COUCH, F., REBBECK, T.R., NEUHAUSEN, S., and GODWIN A.K. (1996). Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat. Med. 2(11), 1179-1183.
32. VOLK, N., and POMPE-KIRN, V. (1997). Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Control 8, 764-770.
33. WACHOLDER, S., HARTGE, P., STRUEWING, J.P., et al. (1998). The kin-cohort study for estimating penetrance. Am. J. Epidemiol. 148, 623-630.
34. WOLOSHIN, S., SCHWARTZ, L.M., MONCUR, M., et al. (2001). Assessing values for health: Numeracy matters. Med. Decis. Mak. 21, 380-388.